startup.bid
ZH-HANT
EnglishEspañolPortuguêsFrançaisDeutschItalianoNederlandsSvenskaDanskNorskPolskiSlovenščinaTürkçeРусскийBahasa IndonesiaBahasa MelayuFilipinoTiếng ViệtKiswahiliहिन्दीاردوالعربيةעברית日本語한국어中文繁體中文

WonderTx

Extrapolative AI to unlock First-in-Class drugs

公司介紹

公司介紹(英文原文)

We’re an AI-native biotech, working on replacing needles with pills. Many drugs, like insulin or Ozempic, are wonderful except you have to inject them. We discover new molecules that you can take as a pill instead. Because the pills operate on biology which has been shown to be effective in people, rather than merely in animal models of disease, we avoid what has historically been the single biggest risk in drug discovery.  This should dramatically increase our probability of success.

There’s $200B of treatable diseases and validated human biology without a pill because discovery programs lack a tractable chemical starting point. This is a zero-shot inference problem, because these targets have no training data, so LLMs and other historical interpolative AI approaches are insufficient. Instead, we are building our own extrapolative frontier models that reason beyond their training data. Most critically, we have repeatedly validated our platform on both our own and partner programs. On 4 biologically- and structurally-diverse targets where we had zero training data, we successfully picked binders that were validated experimentally, with confirmation ranging from primary screen hits to crystallographic structures.

主題

所在地
舊金山, CA, 美國
團隊規模
3 名員工
YC 梯次
Summer 2026
狀態
營運中
階段
早期階段

同類新創公司與競爭對手

常見問題

WonderTx 的總部在哪裡?

舊金山, CA, 美國

WonderTx 有多少員工?

根據公司簡介,共有 3 名員工。

WonderTx 是否獲得過融資?

我們的資料中沒有 WonderTx 的融資紀錄。

WonderTx 有哪些替代選擇?

類似的新創公司:Diffuse Bio、Output Labs和Numerion Labs。